Shanghai-headquartered venture capital firm, Qiming Venture Partners, has secured $3.2 billion in its latest fundraise.

  • The fund was raised as $2.5 billion in Fund VIII and $700 million in Fund VII.
  • The VC firm has invested in more than 480 companies with 70 becoming unicorns.
  • Its portfolio includes Xiaomi, Gan & Lee Pharmaceuticals, Tigermed, Zai Lab, CanSino Biologics, APT Medical, Meituan, Bilibili, and Roborock.
  • Gary Rieschel founded Qiming in 2006 in Shanghai and the firm has raised $9.6 billion to date.